Advertisement
Advertisement
AGEN
Agenus Inc.
7.13
USDSponsored
+0.19
+2.74%
Sep 14, 15:59 UTC -4
Closed
After-Market
7.15
+0.02
+0.28%
AGEN Earnings Reports
Positive Surprise Ratio
AGEN beat 21 of 43 last estimates.
49%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$36.21M
/-$0.01
Implied change from Q2 26 (Revenue/ EPS)
+4.96%
/--
Implied change from Q3 25 (Revenue/ EPS)
+19.76%
/-100.52%
Agenus Inc. earnings per share and revenue
On Aug 06, 2026, AGEN reported earnings of -0.01 USD per share (EPS) for Q2 26, missing the estimate of 0.05 USD, resulting in a -119.61% surprise. Revenue reached 34.50 million, compared to an expected 34.68 million, with a -0.52% difference. The market reacted with a -3.73% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 36.21 million USD, implying an increase of 0.00% EPS, and increase of 4.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Attovia Therapeutics, Inc. Common Stock
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$2.78
Actual
-$4.88
Surprise
-75.25%
Scribe Therapeutics Inc. Common Stock
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$3.03
Actual
-$2.62
Surprise
+13.59%
enGene Therapeutics Inc. Common Stock
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Immutep Limited - ADR
Report Date
Sep 01, 2026 For Q4 26
Estimate
$0.00
Actual
-$0.02
Surprise
-2,500.00%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Agenus Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Agenus Inc. reported EPS of -$0.01, missing estimates by -119.61%, and revenue of $34.50M, -0.52% below expectations.
How did the market react to Agenus Inc.'s Q2 2026 earnings?
The stock price moved down -3.73%, changed from $7.78 before the earnings release to $7.49 the day after.
When is Agenus Inc. expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Agenus Inc.'s next earnings report?
Based on 3
analysts, Agenus Inc. is expected to report EPS of -$0.01 and revenue of $36.21M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.